作者:Kazuo Ohta、Osamu Miyagawa、Hironori Tsutsui、Oyo Mitsunobu
DOI:10.1246/bcsj.66.523
日期:1993.2
grahamimycin A1 (1). The O-7–C-14 fragment [(4S,5S,7R)- or (4R,5R,7R)-7-hydroxy-4,5-isopropylidenedioxyoctanoate] was synthesized from 4,6-dideoxy-α-D-xylo -hexopyranoside. Condensation of the both fragments, followed by deprotection at the terminal hydroxyl- and carboxyl-functions afforded the seco acids of the precursors of 1. While the reaction of the seco acids having 13S-configuration with diethyl azodicarboxylate
(3R)- 和 (3S)-3-羟基丁酸酯分别转化为 (2E,5R)- 和 (2E,5S)-5-t-丁基二甲基甲硅烷氧基-2-己烯酸,对应于 O-1-C-6 Grahamimycin A1 (1) 的片段。O-7–C-14 片段 [(4S,5S,7R)- 或 (4R,5R,7R)-7-hydroxy-4,5-isopropylidenedioxyoctanoate] 由 4,6-dideoxy-α-D-合成木糖苷。两个片段的缩合,然后在末端羟基和羧基官能团上脱保护得到前体 1 的 seco 酸。 而具有 13S-构型的 seco 酸与偶氮二羧酸二乙酯和三苯基膦的反应在低浓度下提供相应的内酯产率,具有 13R-构型的癸二酸通过 Yamaguchi 程序的大环内酯化以 56% 的产率得到所需的内酯。